Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Soo Chin Ng"'
Autor:
Sang Eun Yoon, Yuqin Song, Seok Jin Kim, Dok Hyun Yoon, Tsai-Yun Chen, Youngil Koh, Ka Won Kang, Ho Sup Lee, Kevin Kuang Wei Tay, Soon Thye Lim, Michele Poon, Cosphiadi Irawan, Weili Zhao, Young Rok Do, Mark Hong Lee, Soo Chin Ng, Won-Sik Lee, Ye Guo, Huilai Zhang, Hye Jin Kang, Hwan Jung Yun, Hyo Jung Kim, Daryl Tan Chen Lung, Jae-Yong Kwak, Jae Joon Han, Yeung-Chul Mun, Sung Yong Oh, Hyeok Shim, Jung Hye Kwon, Byeong Seok Sohn, Seong Kyu Park, Jae-Cheol Jo, Young Hyeh Ko, Zhu Jun, Won Seog Kim
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 10, Iss , Pp 100126- (2021)
Background: Peripheral T-cell lymphomas (PTCLs) are uncommon and their frequency is regionally heterogeneous. Several studies have been conducted to evaluate the clinical features and treatment outcomes of this disease entity, but the majority of the
Externí odkaz:
https://doaj.org/article/7bd9491e02234f29aebb00e8c11f836c
Autor:
Chin Sum Cheong, Sen Mui Tan, Soo Chin Ng, Tee Chuan Ong, Sharifah Shahnaz Syed Abd Kadir, Kim Wah Ho, Alan Teh, Haris Abdul Rahman, Ping Chong Bee, Naomi Aoki, Pin-Yen Chen, Erica M. Wood, Andrew Spencer, Elizabeth M. Moore, Wee Joo Chng, Gin Gin Gan
Publikováno v:
Blood. 140:12541-12543
Autor:
Eric Tse, Yok Lam Kwong, Yeow Tee Goh, Ping Chong Bee, Soo Chin Ng, Daryl Tan, Priscilla Caguioa, Huynh Nghia, Teresita Dumagay, Lalita Norasetthada, Suporn Chuncharunee, Vivek Radhakrishnan, Bhausaheb Bagal, Tubagus Djumhana Atmakusuma, Nadia Ayu Mulansari
Publikováno v:
Clinical and Experimental Medicine.
In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limit
Autor:
Mohd Haris Fadzillah Abdul Rahman, Radzi Bin Ahmad Ahmad Badruddin, Kwang Jeat Chong, Mastura Md Yusof, Kai Seng Lam, John Low, Beng Khiong Yap, Soo Chin Ng, Matin Mellor Abdullah, Muhammad Azrif Ahmad Annuar, Kah Liew Lau, Christina Nye Bing Lai, Joel Gabriel Nonis
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 18(4)
AIM A large proportion of cancer patients are at high risk for chemotherapy-induced nausea and vomiting (CINV), but the choice of anti-emetics for CINV in Malaysia is limited. METHODS This was a real-world study of a fixed-dose combination of netupit
Autor:
Young Rok Do, Zhu Jun, Weili Zhao, Hyeok Shim, Jung Hye Kwon, Yeung-Chul Mun, Young Il Koh, Ka Won Kang, Jae Yong Kwak, Ye Guo, Seong Kyu Park, Ho Sup Lee, Cosphiadi Irawan, Young Hyeh Ko, Kevin Tay Kuang Wei, Hyo Jung Kim, Yong Pyo Lee, Won Seog Kim, Won Sik Lee, Huilai Zhang, Hwan Jung Yun, Seok Jin Kim, Sung Yong Oh, Mark Hong Lee, Tsai Yun Chen, Hye Jin Kang, Dok Hyun Yoon, Byeong Seok Sohn, Jae Cheol Jo, Jae Joon Han, Sang Eun Yoon, Yuqin Song, Soo Chin Ng, Daryl Tan Chen Lung, Michelle Poon, Soon Thye Lim
Publikováno v:
International journal of hematology. 114(3)
Cutaneous T-cell lymphomas (CTCLs) are a group of T-cell lymphomas with low incidence. Due to their indolent characteristics, treatment strategies have not yet been established for advanced CTCLs. In this study, relative incidence of CTCLs in Asia wa
Autor:
Won Seog Kim, Cosphiadi Irawan, Wei-Li Zhao, Ka Won Kang, Young Rok Do, Seong Kyu Park, Youngil Koh, Ye Guo, Mark Hong Lee, Hye Jin Kang, Michelle Poon, Jae Cheol Jo, Jung Hye Kwon, Byeong Seok Sohn, Won Sik Lee, Zhu Jun, Kevin Tay, Yuqin Song, Seok Jin Kim, Sung Yong Oh, Yeung-Chul Mun, Soon Thye Lim, Tsai Yun Chen, Soo Chin Ng, Ho Sup Lee, Hyeok Shim, Dok Hyun Yoon, Sang Eun Yoon, Jae Joon Han, Hyo Jung Kim, Huilai Zhang, Daryl Tan Chen Lung, Hwan Jung Yun, Young Hyeh Ko, Jae Yong Kwak
Publikováno v:
The Lancet Regional Health: Western Pacific
The Lancet Regional Health. Western Pacific, Vol 10, Iss, Pp 100126-(2021)
The Lancet Regional Health. Western Pacific, Vol 10, Iss, Pp 100126-(2021)
Background: Peripheral T-cell lymphomas (PTCLs) are uncommon and their incidence is regionally heterogeneous. Several studies have been conducted to evaluate the clinical features and treatment outcomes of this disease entity, but the majority of the
Autor:
Soo Chin Ng, Nur Adila Anuar, Gin Gin Gan, Alan Kee Hean Teh, Mohd Haris Fadzillah Abdul Rahman, Kevin Wen Fei Tey, Bee Ping Chong
Publikováno v:
International Journal of Clinical Practice. 75
Aim To retrospectively report the clinical outcomes of non-Hodgkin's Lymphoma (NHL) patients post high dose therapy (HDT) with autologous haematopoietic stem cell transplant (AHSCT) and determine whether upfront transplant, which is a first-line cons
Autor:
Kevin Wen Fei Tey, Bee Ping Chong, Mohd Haris Fadzillah Abdul Rahman, Gin Gin Gan, Nur Adila Anuar, Soo Chin Ng, Alan Kee Hean Teh
There is scarce information available in regards to the survival outcome of non-Hodgkin lymphoma (NHL) in South East Asia regions. Reports on the outcome of High dose therapy followed by autologous haematopoietic stem cell transplantation (AHSCT) wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6845c37d80ced1e983aa5584b9c16f2
https://doi.org/10.22541/au.159200630.09329491
https://doi.org/10.22541/au.159200630.09329491
Autor:
Jae-Cheol Jo, Daryl Tan, Cosphiadi Irawan, Cheolwon Suh, Hyo Jung Kim, Huilai Zhang, Won Seog Kim, Hwan Jung Yun, Young Rok Do, Yeung-Chul Mun, Byeong Seok Sohn, Soon Thye Lim, Soo Chin Ng, Jun Zhu, Li Mei Poon, Hong-ghi Lee, Yong Park, Sang Eun Yoon, Jae-Yong Kwak, Seok Jin Kim, Weili Zhao, Ye Guo, Sung Yong Oh, Seong Kyu Park, Hye Jin Kang, Ho Sup Lee, Won Sik Lee, Tsai Yun Chen, Jae Joon Han
Publikováno v:
Blood. 134:4035-4035
Introduction T-cell lymphoma is a group of heterogeneous diseases with various clinical behaviors and treatment outcomes, representing 10-15% of non-Hodgkin lymphomas. Owing to its rarity and heterogeneity, the standard treatment approach for T-cell
Autor:
Kevin Tay, Won Seog Kim, Yiong Huak Chan, Soon Thye Lim, Daryl Tan, Sathish Kumar, Colin Phipps, S Fadilah, Chun Hsien Yeap, William Hwang, Soo Yong Tan, Yeow Tee Goh, Soo Chin Ng, Yuh Shan Lee
Publikováno v:
The Lancet Haematology. 2:e326-e333
Summary Background Patients with relapsed or refractory peripheral T-cell lymphoma have a poor prognosis after conventional chemotherapy. Approved novel agents have only modest single-agent activity in most subtypes of peripheral T-cell lymphoma. Pan